相关实验视频
Updated: Jul 12, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.3K
慢性病患者的铁状况标志物和结局之间的关联
Hironobu Fujisawa1, Masaru Nakayama2, Naoki Haruyama1
1Division of Nephrology, Department of Internal Medicine, NHO Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka City, 810-8563, Japan.
Scientific reports
|October 25, 2023
概括
铁状况标志物,如转林和度 (TSAT) 和血清费里丁,影响慢性病 (CKD) 的进展. 低和高的费里水平独立地预测了慢性病患者脏结果的恶化.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床医学 临床医学
- 生物化学 生物化学
背景情况:
- 慢性病 (CKD) 影响全球数百万人,铁状况标志物经常受到监测.
- 关于铁状况标志物 (转林和 (TSAT) 和血清费里丁) 与慢性病患者结局之间的关联的先前研究产生了不一致的结果.
- TSAT,血清费里丁和CKD进展之间的确切关系仍然是争论的主题.
研究的目的:
- 调查TSAT和血清费里水平以及CKD患者的结局之间的关联.
- 澄清铁状况标记在预测病进展中的作用.
主要方法:
- 一项前性队列研究,涉及890名被评估为CKD的患者.
- 根据TSAT或血清费里水平,患者被分为四分之一.
- 主要结局:血清肌素的翻倍,末期病或衰竭死亡的复合结果,使用多变量Cox和Fine-Gray模型进行分析.
主要成果:
- 与第三个四分位数相比,TSAT四分位数和脏结果之间没有发现显著的关联.
- 与第二四分位数 (Q2) 相比,较低 (Q1) 和较高 (Q3,Q4) 的血清费里水平显著与结局风险增加有关.
- 细灰竞争性风险分析证实了这些发现,表明费里水平是独立的风险因素.
结论:
- 低和高的血清费里水平是CKD患者病进展的独立风险因素.
- 在这个队列中,TSAT水平与脏结果没有显著的关联.
- 这些发现突出了铁代谢在CKD进展中的复杂作用,并建议费里丁作为潜在的预测标记物.
相关概念视频
01:24Chronic Kidney Disease II: Clinical Manifestations
12
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
12
01:25Chronic Kidney Disease I: Introduction
18
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
18
01:28Chronic Kidney Disease III: Interprofessional Care
21
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
21
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
19
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
19
01:22Acute Kidney Injury I: Introduction
14
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
14
01:29Acute Kidney Injury III: Clinical Manifestations
13
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
13